Chemed Corporation $CHE Stock Position Raised by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. increased its position in Chemed Corporation (NYSE:CHE) by 2,444,879.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,550,103 shares of the company’s stock after purchasing an additional 5,549,876 shares during the period. Chemed comprises about 1.2% of Northwestern Mutual Wealth Management Co.’s investment portfolio, making the stock its 14th biggest holding. Northwestern Mutual Wealth Management Co. owned 39.20% of Chemed worth $2,374,667,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC boosted its position in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the period. First Horizon Corp acquired a new position in Chemed during the third quarter valued at $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Chemed during the third quarter valued at $45,000. Danske Bank A S lifted its stake in Chemed by 250.0% in the 4th quarter. Danske Bank A S now owns 140 shares of the company’s stock worth $60,000 after acquiring an additional 100 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its stake in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 3.33% of the stock is currently owned by company insiders.

Chemed Stock Up 1.9%

CHE opened at $434.43 on Friday. The company has a market capitalization of $5.76 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 1.60 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The business has a 50-day moving average of $396.73 and a 200-day moving average of $425.22.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts forecast that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CHE has been the topic of several research analyst reports. Oppenheimer lowered their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.